Ameriprise’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.07M Buy
207,787
+9,885
+5% +$98.6K ﹤0.01% 2918
2025
Q1
$1.18M Sell
197,902
-7,286
-4% -$43.5K ﹤0.01% 3114
2024
Q4
$1.58M Buy
205,188
+143,672
+234% +$1.1M ﹤0.01% 3030
2024
Q3
$628K Sell
61,516
-17,953
-23% -$183K ﹤0.01% 3397
2024
Q2
$1.18M Buy
79,469
+685
+0.9% +$10.2K ﹤0.01% 3092
2024
Q1
$1.07M Buy
78,784
+6,064
+8% +$82.7K ﹤0.01% 3132
2023
Q4
$796K Sell
72,720
-60,499
-45% -$662K ﹤0.01% 3284
2023
Q3
$1.46M Sell
133,219
-215
-0.2% -$2.35K ﹤0.01% 2976
2023
Q2
$1.77M Sell
133,434
-5,206
-4% -$68.9K ﹤0.01% 2935
2023
Q1
$1.89M Buy
138,640
+16,653
+14% +$227K ﹤0.01% 2874
2022
Q4
$2.38M Sell
121,987
-176,346
-59% -$3.44M ﹤0.01% 2725
2022
Q3
$5.68M Buy
298,333
+203,749
+215% +$3.88M ﹤0.01% 2118
2022
Q2
$1.95M Buy
94,584
+5,285
+6% +$109K ﹤0.01% 2818
2022
Q1
$2.87M Buy
+89,299
New +$2.87M ﹤0.01% 2750